Berkeley Brochures
-
Opto™ Cell Therapy Development Workflow: Cytotoxicity Assay
1/22/2021
The Opto™ Cell Therapy Development workflow Cytotoxicity Assay enables kinetic analysis of killing activity from single T cells, followed by live cell recovery for genomic analysis. This assay avoids common problems associated with traditional killing assays, which measure average target cell lysis at fixed time points, obscuring kinetic details and ignoring the heterogeneity present in T cell subsets.
-
Lightning™ Optofluidic System Brochure
1/22/2021
Identifying T cell functional signatures is a long, laborious, and complex process that requires you to draw conclusions from surrogate measurements collected on multiple platforms. The Lightning system changes this by allowing you to directly visualize the phenotype and function of 1000s of individual cells in just days and recover cells of interest alive.
-
Opto™ Cell Therapy Development Workflow: TCRseq Well Plate Kit
1/22/2021
Used downstream of functional T cell assays in the Opto™ Cell Therapy Development workflows, the TCRseq kit enables recovery of functionally validated T cell receptors (TCRs) from fewer than 10,000 input cells. Instead of re-expressing hundreds of TCRs in the hopes of identifying the rare sequence that imparts ideal specificity, the kit allows users to only sequence the T cells that matter.